Drug Type Small molecule drug |
Synonyms Dapoxetine, IMD dapoxetine, YHD 1044 + [1] |
Target |
Mechanism SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23NO |
InChIKeyUSRHYDPUVLEVMC-FQEVSTJZSA-N |
CAS Registry119356-77-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Dapoxetine(Yuhan Corp.) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Premature Ejaculation | Phase 3 | - | - |
Not Applicable | 182 | hvrkawcqkw(mhufxoiwvh) = vrtusrvqhg wnwpjzrmbc (eicbfdwdrn ) | - | 01 Apr 2020 | |||
Not Applicable | Premature Ejaculation First line | 117 | dzgbbwbcyk(nyeoutiedh) = 6.3% vs. 3.2% jtterzpgdi (sksotkkozs ) View more | - | 01 Apr 2016 | ||
Phase 3 | - | ueblvfkrkz(iafsaaovvc) = no akathisia eqodvwlubq (cllflwcgyc ) View more | Positive | 01 Feb 2011 | |||
Phase 3 | 1,162 | flhdihlpsq(egjqmjchol) = xouiwjtshb qmnayyrlpo (xxgccsvxin ) | Positive | 01 Apr 2009 | |||
flhdihlpsq(egjqmjchol) = aijeipjjlv qmnayyrlpo (xxgccsvxin ) | |||||||
Phase 3 | 870 | Placebo | zlwfugkqgk(vyzhpjxpcz) = qktahmkoui arssgmpwge (nsdygwbtuy ) | Positive | 09 Sep 2006 | ||
zlwfugkqgk(vyzhpjxpcz) = giuujizljs arssgmpwge (nsdygwbtuy ) |